Invitation to Idorsia’s full year financial results 2020 webcast and conference call
Idorsia will publish its full year financial results 2020 on Thursday February 4, 2021, at…
Idorsia will publish its full year financial results 2020 on Thursday February 4, 2021, at…
OSE is advancing an “Immunotherapy 2.0” future by leveraging MAbSilico’s artificial intelligence-powered software solutions and…
TORONTO, Jan. 28, 2021 (GLOBE NEWSWIRE) — Biosenta Inc. (“Biosenta” or the “Company”) listed on…
DAVIS, Calif., Jan. 28, 2021 (GLOBE NEWSWIRE) — Marrone Bio Innovations, Inc. (NASDAQ: MBII), an…
REHOVOT, Israel and WILMINGTON, Del., Jan. 28, 2021 (GLOBE NEWSWIRE) — Ayala Pharmaceuticals, Inc. (NASDAQ:…
Clinical team led by neurological gene therapy expert, Dr. Krystof Bankiewicz, joins AskBio RESEARCH TRIANGLE…
– Company licenses exclusive worldwide rights to develop, manufacture and commercialize targeted, highly specific immunosuppressive…
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Jan. 28, 2021 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation…
SAN DIEGO, Jan. 28, 2021 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”) in…
Upon closing, the company to meet Nasdaq listing requirements without the need to effect a…
Webinar on Thursday, February 4, at 12:00 PM ET REDWOOD CITY, Calif., Jan. 28, 2021…
George Goldsmith, Chairman & CEO, to deliver opening day keynote on 3 February London, UK,…
GRF6019 was safe and well-tolerated, and patients experienced no cognitive decline and minimal functional decline…
Deep Tissue Gel RHO Phyto Deep Tissue Gels RHO Phyto Deep Tissue Gels will be…
New hire helps lead Aquestive’s continued focus on its epinephrine program Provides update on Libervant™…
DENVER, Jan. 28, 2021 (GLOBE NEWSWIRE) — Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE:…
WATERTOWN, Mass., Jan. 28, 2021 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company…
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICESOR FOR DISSEMINATION IN THE UNITED STATES CALGARY,…
Revenue and EBITDA in line with guidance for 2020. Year-end cash position better than guided…
Darigabat now the international nonproprietary name (INN) for CVL-865, a Phase 2 GABA Positive Allosteric…